iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Burns J W & Co. Inc. NY

Burns J W & Co. Inc. NY lessened its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 1.3% in the 3rd quarter, Holdings Channel reports. The firm owned 19,648 shares of the financial services provider’s stock after selling 260 shares during the period. Burns J W & Co. Inc. NY’s holdings in iShares Biotechnology ETF were worth $2,861,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in IBB. Future Financial Wealth Managment LLC acquired a new position in shares of iShares Biotechnology ETF in the first quarter worth $27,000. Bbjs Financial Advisors LLC acquired a new position in shares of iShares Biotechnology ETF in the second quarter worth $31,000. Pacifica Partners Inc. grew its stake in shares of iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 130 shares in the last quarter. YHB Investment Advisors Inc. acquired a new position in shares of iShares Biotechnology ETF in the first quarter worth $37,000. Finally, Mather Group LLC. acquired a new position in shares of iShares Biotechnology ETF in the first quarter worth $57,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB traded up $1.29 during trading on Friday, hitting $143.90. The company’s stock had a trading volume of 650,133 shares, compared to its average volume of 1,493,461. The business has a 50 day moving average price of $145.48 and a two-hundred day moving average price of $139.10. iShares Biotechnology ETF has a fifty-two week low of $111.83 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.